Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Combination efficacy of ruxolitinib with standard-of-care drugs in CRLF2-rearranged Ph-like acute lymphoblastic leukemia
Julia Böhm, Keith C.S. Sia, Connor Jones, et al.
Leukemia (2021) Vol. 35, Iss. 11, pp. 3101-3112
Closed Access | Times Cited: 23

Showing 23 citing articles:

JAK/STAT in leukemia: a clinical update
Dong Liang, Qiao-Li Wang, Wenbiao Zhang, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 21
Recent Advances in Treatment Options for Childhood Acute Lymphoblastic Leukemia
Marta Malczewska, Kamil Kośmider, Kinga Bednarz, et al.
Cancers (2022) Vol. 14, Iss. 8, pp. 2021-2021
Open Access | Times Cited: 41
Development of Potent and Selective Janus Kinase 2/3 Directing PG–PROTACs
Lisa J. Alcock, Yunchao Chang, Jamie Jarusiewicz, et al.
ACS Medicinal Chemistry Letters (2022) Vol. 13, Iss. 3, pp. 475-482
Open Access | Times Cited: 24
Comprehensive detection of CRLF2 alterations in acute lymphoblastic leukemia: a rapid and accurate novel approach
José Vicente Gil, Alberto Miralles, Sandra de las Heras, et al.
Frontiers in Molecular Biosciences (2024) Vol. 11
Open Access | Times Cited: 5
Glucocorticoid Therapy in Acute Lymphoblastic Leukemia: Navigating Short-Term and Long-Term Effects and Optimal Regimen Selection
Hoda Pourhassan, Lindsey Murphy, Ibrahim Aldoss
Current Hematologic Malignancy Reports (2024) Vol. 19, Iss. 4, pp. 175-185
Open Access | Times Cited: 5
JAK2 Alterations in Acute Lymphoblastic Leukemia: Molecular Insights for Superior Precision Medicine Strategies
Charlotte E. J. Downes, Barbara J. McClure, Daniel P. McDougal, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 20
Application of Omics Analyses in Pediatric B-Cell Acute Lymphoblastic Leukemia
Megi Vllahu, Maria Flavia Savarese, Immacolata Cantiello, et al.
Biomedicines (2025) Vol. 13, Iss. 2, pp. 424-424
Open Access
Full-spectral genome analysis of natural killer/T cell lymphoma highlights impacts of genome instability in driving its progression
Zegeng Chen, He Huang, Huangming Hong, et al.
Genome Medicine (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 3
Clinical screening for Ph-like ALL and the developing role of TKIs
Thai Hoa Tran, Sarah K. Tasian
Hematology (2022) Vol. 2022, Iss. 1, pp. 594-602
Open Access | Times Cited: 15
Philadelphia-like acute lymphoblastic leukemia: the journey from molecular background to the role of bone marrow transplant—review article
Reham Alghandour, Doaa H. Sakr, Yasmine Shaaban
Annals of Hematology (2023) Vol. 102, Iss. 6, pp. 1287-1300
Open Access | Times Cited: 7
Efficacy of ruxolitinib in acute lymphoblastic leukemia: A systematic review
Julia Kołodrubiec, Marta Kozłowska, Ninela Irga‐Jaworska, et al.
Leukemia Research (2022) Vol. 121, pp. 106925-106925
Closed Access | Times Cited: 12
Overcoming Steroid Resistance in Pediatric Acute Lymphoblastic Leukemia—The State-of-the-Art Knowledge and Future Prospects
Kamil Kośmider, Katarzyna Karska, Agata Kozakiewicz, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3795-3795
Open Access | Times Cited: 10
Translational advances in the treatment of childhood acute lymphoblastic leukemia: narrative review of current and emerging molecular and immunotherapies
Faryal Munir, Jiasen He, Jeremy Connors, et al.
Translational Pediatrics (2023) Vol. 12, Iss. 3, pp. 487-502
Open Access | Times Cited: 6
The Role of the JAK–STAT Pathway in Childhood B-Cell Acute Lymphoblastic Leukemia
Karolina Ziętara, Kinga Wróblewska, Monika Zajączkowska, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 6844-6844
Open Access | Times Cited: 1
BCL6 inhibition ameliorates resistance to ruxolitinib in <i>CRLF2</i>-rearranged acute lymphoblastic leukemia
Shinobu Tsuzuki, Takahiko Yasuda, Hiroaki Goto, et al.
Haematologica (2022) Vol. 108, Iss. 2, pp. 394-408
Open Access | Times Cited: 7
Drug-tolerant persister B-cell precursor acute lymphoblastic leukemia cells
Mingfeng Zhang, Lu Yang, David Chen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 3
Combinational treatment of TPEN and TPGS induces apoptosis in acute lymphoblastic and chronic myeloid leukemia cells in vitro and ex vivo
Miguel Mendivil‐Perez, Marlene Jiménez-Del-Río, Carlos Velez‐Pardo
Medical Oncology (2022) Vol. 39, Iss. 7
Closed Access | Times Cited: 4
Co-targeting of the thymic stromal lymphopoietin receptor to decrease immunotherapeutic resistance in CRLF2-rearranged Ph-like and Down syndrome acute lymphoblastic leukemia
Tommaso Balestra, Lisa M Niswander, Asen Bagashev, et al.
Leukemia (2024)
Open Access
New Agents
Francisco Bautista, C. Michel Zwaan, Andrej Lissat
Pediatric oncology (2024), pp. 373-397
Closed Access
Ruxolitinib inhibits the proliferation and induces the apoptosis of MLL-r ALL cells through inactivating JAK/STAT signaling pathway
Xiong‐yu Liao, Dun‐hua Zhou, Jian‐Pei Fang, et al.
Translational Pediatrics (2023) Vol. 12, Iss. 6, pp. 1088-1097
Open Access | Times Cited: 1
JAK-ing up treatment for CRLF2-R ALL
Adele K. Fielding
Blood (2022) Vol. 139, Iss. 5, pp. 645-646
Open Access | Times Cited: 1
Strategies for Targeting the JAK ‐ STAT Pathway in Lymphoid Malignancies
David J. Feith, Johnson Ung, Omar Elghawy, et al.
(2023), pp. 381-401
Closed Access
BCR::ABL1-like acute lymphoblastic leukaemia: a single institution experience on identification of potentially therapeutic targetable cases
Anna Płotka, Anna Przybyłowicz-Chalecka, Maria Korolczuk, et al.
Molecular Cytogenetics (2023) Vol. 16, Iss. 1
Open Access
Page 1

Scroll to top